HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

New UK Health Secretary Wants More OTCs Available And Greater Role For Pharmacists

Executive Summary

More medicines available without a prescription and more responsibility for community pharmacists are two of the goals set out by the UK's new Secretary of State for Health and Social Care.

You may also be interested in...



UK Industry Urges Government to Develop Self-Care Strategy

UK consumer healthcare industry association PAGB has joined forces with a number of like-minded groups to call on the government to implement a national strategy for self-care to help relieve pressure on the NHS.

HRA Pharma And Maxwellia To Launch The UK’s First OTC Daily Contraceptives

The UK's MHRA has approved the Rx-to-OTC switch of two identical progestogen-only contraceptive pills from HRA Pharma and Maxwellia. Hana and Lovima (both 75mcg desogestrel) will be launched at the end of the month. 

Instagram Now Social Network Of Choice For Spain’s OTC Firms As Market Grows Double-Digits

Instagram is now the most important social network for Spanish OTC companies, according to the results of a recent survey by the country’s self-care industry association, ANEFP. Meanwhile, ANEFP predicts 11% growth in the country's self-care market by the end of 2022.

Topics

Latest News
See All
UsernamePublicRestriction

Register

RS152954

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel